NCT02490449Unknown不适用
Dexlansoprazole MR in Nonerosive Reflux Disease
适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 入组人数
- 356
- 试验地点
- 1
- 主要终点
- Percentage (%) of patients free of reflux symptoms
研究概览
简要总结
This study aim is to compare the efficacy of Dexlansoprazole MR intake before and after breakfast in patients with nonerosive reflux disease.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 19 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •NERD confirmed by gastroscopy
排除标准
- •PPI medication within 2 weeks before enrollment
研究组 & 干预措施
Exprerimental group
Experimental
medication after diet
干预措施: Dexlansoprazole MR (Drug)
control group
Active Comparator
medication before diet
干预措施: Dexlansoprazole MR (Drug)
结局指标
主要结局
Percentage (%) of patients free of reflux symptoms
时间窗: 4 weeks
次要结局
未报告次要终点
研究者
Su Jin Hong
professor
Soonchunhyang University Hospital
研究点 (1)
Loading locations...
相似试验
已完成
1 期
Effect of Dexlansoprazole on Bone HomeostasisHomeostasisBone and BonesNCT01216293Takeda115
已完成
1 期
Pharmacokinetic and Safety of Dexlansoprazole in Adolescents With Gastroesophageal Reflux DiseaseGastroesophageal RefluxNCT00847210Takeda36
已完成
1 期
Study to Evaluate the Pharmacokinetics and Safety of Dexlansoprazole in Pediatric Subjects With Symptomatic Gastroesophageal Reflux DiseaseGastroesophageal RefluxNCT01045096Takeda36
已完成
4 期
An Efficacy Study to Compare the Treatment Effects of Rabeprazole and Lansoprazole Depending on the Genotyping of CYP2C19 in Treating Reflux EsophagitisReflux EsophagitisNCT01008696Janssen Korea, Ltd., Korea217
已完成
3 期
A Study of Dexlansoprazole Modified Release Formulation to Treat Night HeartburnGastroesophageal RefluxNCT00627016Takeda305